PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 56 filers reported holding PROQR THRAPEUTICS N V in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $798,000 | -36.7% | 138,461 | 0.0% | 1.44% | -22.6% |
| Q2 2019 | $1,260,000 | -34.4% | 138,461 | 0.0% | 1.86% | -28.4% |
| Q1 2019 | $1,920,000 | -12.1% | 138,461 | 0.0% | 2.60% | -45.9% |
| Q4 2018 | $2,185,000 | -18.4% | 138,461 | 0.0% | 4.81% | -24.8% |
| Q3 2018 | $2,679,000 | +138.6% | 138,461 | -10.0% | 6.40% | +162.7% |
| Q2 2018 | $1,123,000 | +137.4% | 153,846 | 0.0% | 2.44% | +162.4% |
| Q1 2018 | $473,000 | -52.3% | 153,846 | -50.0% | 0.93% | +8.2% |
| Q4 2017 | $992,000 | – | 307,692 | – | 0.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 2,401,570 | $14,602,000 | 2.94% |
| DAFNA Capital Management LLC | 1,237,400 | $7,523,000 | 2.17% |
| RTW INVESTMENTS, LP | 4,902,785 | $29,809,000 | 0.84% |
| Kerrisdale Advisers, LLC | 453,182 | $2,755,000 | 0.31% |
| COWEN AND COMPANY, LLC | 300,042 | $1,824,000 | 0.30% |
| Artal Group S.A. | 1,259,177 | $7,656,000 | 0.21% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,550,062 | $27,664,000 | 0.07% |
| ALTRINSIC GLOBAL ADVISORS LLC | 221,360 | $1,346,000 | 0.06% |
| FRANKLIN STREET ADVISORS INC /NC | 60,000 | $365,000 | 0.04% |
| JENNISON ASSOCIATES LLC | 2,625,514 | $15,963,000 | 0.01% |